These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 192411)

  • 1. Bromocriptine for Cushing's disease.
    Kennedy AL; Montgomery DA
    Br Med J; 1977 Apr; 1(6068):1083-4. PubMed ID: 192411
    [No Abstract]   [Full Text] [Related]  

  • 2. Bromocriptine in Nelson's syndrome and Cushing's disease.
    Lamberts SW; Birkenhäger JC
    Lancet; 1976 Oct; 2(7989):811. PubMed ID: 61490
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of bromocriptine in pituitary-dependent Cushing's syndrome.
    Lamberts SW; Birkenhäger JC
    J Endocrinol; 1976 Aug; 70(2):315-6. PubMed ID: 184231
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of Cushing's disease successfully treated with bromocriptine.
    Sumiya N; Hiramatsu K; Arimori S
    Jpn J Med; 1990; 29(2):185-90. PubMed ID: 2172607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2 cases of Cushing's syndrome successfully treated with bromocriptine].
    Medraś M; Plamieniak Z; Bidzińska B
    Pol Tyg Lek; 1988 Sep; 43(39):1263-5. PubMed ID: 2854251
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's disease: clinical and laboratory response to bromocriptine therapy.
    de Pinho MO; Antunes RC; Lima MB; Francalanci CC; Franco S
    J Endocrinol Invest; 1984 Dec; 7(6):585-8. PubMed ID: 6099377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six year remission of ACTH-dependent Cushing's syndrome using bromocriptine.
    Atkinson AB; Kennedy AL; Sheridan B
    Postgrad Med J; 1985 Mar; 61(713):239-42. PubMed ID: 2984649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of antiserotoninergic and/or dopaminergic treatment in patients with pituitary-dependent Cushing's syndrome.
    Ambrosi B; Gaggini M; Secchi F; Faglia G
    Horm Metab Res; 1979 Apr; 11(4):318-9. PubMed ID: 222663
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclic Cushing's disease in long-term remission with a daily low dose of bromocriptine.
    Adachi M; Takayanagi R; Yanase T; Sakai Y; Ikuyama S; Nakagaki H; Osamura Y; Sanno N; Nawata H
    Intern Med; 1996 Mar; 35(3):207-11. PubMed ID: 8785455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term bromocriptine therapy in Cushing's disease.
    Kapcala LP; Jackson IM
    J Endocrinol Invest; 1982; 5(2):117-20. PubMed ID: 6284830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five cases of cyclical Cushing's syndrome.
    Atkinson AB; Kennedy AL; Carson DJ; Hadden DR; Weaver JA; Sheridan B
    Br Med J (Clin Res Ed); 1985 Nov; 291(6507):1453-7. PubMed ID: 2998540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of pituitary tumor size with clinical and biochemical improvement with bromocriptine in a normoprolactinemic Cushing's disease.
    Hayashi H; Mercado-Asis LB; Murayama M; Yamakita N; Yasuda K; Miura K
    Endocrinol Jpn; 1990 Dec; 37(6):875-82. PubMed ID: 1966282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bromocriptine in pituitary-dependent Cushing's syndrome.
    Boscaro M; Benato M; Mantero F
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):485-91. PubMed ID: 6313262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.
    Kennedy AL; Sheridan B; Montgomery DA
    Acta Endocrinol (Copenh); 1978 Nov; 89(3):461-8. PubMed ID: 212917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome.
    O'Mullane N; Walker B; Jefferson J; Hipkin L; Diver M; Davis C
    J Endocrinol Invest; 1978 Oct; 1(4):355-7. PubMed ID: 229153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone in nonsuppressible Cushing's disease.
    Meikle AW; West CD; Tyler FH
    N Engl J Med; 1980 Aug; 303(6):340. PubMed ID: 6247657
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of responsiveness to bromocriptine of Cushing's disease elevated ACTH.
    del Arbol JL; López-Luque A; Jiménez J; Escobar F; Peña A; Arcelus I; Osorio C
    Arch Farmacol Toxicol; 1977 Aug; 3(2):171-6. PubMed ID: 200187
    [No Abstract]   [Full Text] [Related]  

  • 18. Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.
    T'Sjoen G; Defeyter I; Van De Saffele J; Rubens R; Vandeweghe M
    J Endocrinol Invest; 2002 Feb; 25(2):172-5. PubMed ID: 11929090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium valproate and cyproheptadine may independently induce a remission in the same patient with Cushing's disease.
    Koppeschaar HP; Croughs RJ; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):160-3. PubMed ID: 6314723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of injectable bromocriptine in patients with Cushing's disease.
    Invitti C; De Martin M; Danesi L; Cavagnini F
    Exp Clin Endocrinol Diabetes; 1995; 103(4):266-71. PubMed ID: 7584534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.